Even though most women know deep down that perfection is unattainable, they still strive for it.

More than half of the women in our study still worry about what other people think of them, loved ones and strangers alike.

MONTREAL (PRWEB)
March 07, 2020

International Women’s Day is a celebration of the societal barriers that women have fought long, and fought hard, to break down. Simone de Beauvoir dared to challenge the patriarchy’s belief of a woman’s role, and rights, in society. Frida Kahlo spurred conversation on forbidden topics through her artwork. Mary Church Terrel wasn’t just one of the first African American women to earn a college degree, she was also a strong advocate for women’s right to vote. In spite of the progress women have made in the fight for equality, research from Queendom reveals that many still feel they are not enough … they believe that in order to be loved, respected and accepted, they need to be better, look better, do more, be more, give more.

Analyzing data from nearly 1,000 women who took the Perfectionism Test, data from Queendom’s study indicate that Gen Z girls and Gen Y women feel the most pressure to be perfect. This perceived pressure is less prominent in Gen Xers and Baby Boomers, but still present. Here’s what Queendom’s data revealed:

WOMEN TEND TO SET EXCESSIVELY HIGH PERFORMANCE STANDARDS FOR THEMSELVES

> They are only proud of their work if it receives praise from a teacher/manager.

•      Gen Z: 48%
•      Gen Y: 41%
•      Gen X: 27%
•      BBs: 20%

> They are only satisfied when a task is done perfectly

•      Gen Z: 67%
•      Gen Y: 71%
•      Gen X: 65%
•      BBs: 64%

> They believe that failing an assignment at school/work makes them a failure as a person.

•      Gen Z: 47%
•      Gen Y: 52%
•      Gen X: 48%
•      BBs: 24%

WOMEN TEND TO SET EXCESSIVELY HIGH PERSONAL STANDARDS FOR THEMSELVES

> They want to excel at everything they take on.

•      Gen Z: 66%
•      Gen Y: 71%
•      Gen X: 54%
•      BBs: 56%

> They believe they will never be rejected (by a significant other, by friends, etc.) if they are perfect.

•      Gen Z: 35%
•      Gen Y: 36%
•      Gen X: 30%
•      BBs: 8%

> They constantly worry about making mistakes.

•      Gen Z: 47%
•      Gen Y: 52%
•      Gen X: 56%
•      BBs: 48%

WOMEN FEEL PRESSURE FROM THEIR FAMILY TO BE PERFECT

> They feel that no matter how hard they try, it’s never good enough for their family or partner.

•      Gen Z: 44%
•      Gen Y: 41%
•      Gen X: 37%
•      BBs: 32%

> They are afraid of being criticized if they mess up.

•      Gen Z: 54%
•      Gen Y: 43%
•      Gen X: 37%
•      BBs: 16%

> They have trouble saying no to requests because they don’t want to let people down.

•      Gen Z: 55%
•      Gen Y: 60%
•      Gen X: 54%
•      BBs: 18%

WOMEN FEEL PRESSURE FROM SOCIETY TO BE PERFECT

> The thought of being considered “average” terrifies them.

•      Gen Z: 60%
•      Gen Y: 56%
•      Gen X: 58%
•      BBs: 40%

> They believe that in order to be respected, they need to have a lot of money.

•      Gen Z: 23%
•      Gen Y: 29%
•      Gen X: 13%
•      BBs: 16%

> They believe they have to be in perfect physical shape to be attractive.

•      Gen Z: 51%
•      Gen Y: 46%
•      Gen X: 39%
•      BBs: 40%

“Even though most women know deep down that perfection is unattainable, they still strive for it,” explains Dr. Jerabek, president of PsychTests, the parent company of Queendom. “It’s that duality that causes so much heartache; that constant battle between the woman they want to be, and the woman they feel they need to be. For example, the vast majority of the women in our study said that they are proud of their achievements. Yet, more than half of them still worry about what other people think of them, loved ones and strangers alike. On the one hand, I believe we have come very far in terms of shattering beauty and gender role stereotypes, and making women feel more comfortable with who they are. On the other hand, so many women are still ridden by self-doubt and a need for external validation, still struggle with self-esteem issues and imposter syndrome, and still feel that self-love is selfish and egotistical.”

Why do so many women still feel like they’re not good enough?

“Because this concept of the ‘ideal woman’ still floats around on social media, on television, and in movies – and it’s a moving target. One day, women should be thin, blond influencers. The next day they should emulate the pony-tailed perfect mom who always makes healthy snacks, or the curvy, career-oriented woman. So it’s a constant everyday pressure women put on themselves to be everything to everyone. However, while it is true that women are bombarded with the unrealistic messages about the ideal female, we are as guilty, if not more, of imposing impossible standards on ourselves. We are not helpless victims. We have a voice. We can step into our power without blaming our lack of self-love on society. We can take responsibility for our own happiness – and taming our perfectionism is a great step in the right direction. My hope for women on March 8th is for them to choose to be who they want to be, and to do what their heart calls them to do – and not give a damn about what anyone else thinks.”

Want to assess your perfectionistic tendencies? Check out our Perfectionism Test at https://www.queendom.com/tests/access_page/index.htm?idRegTest=3051

Professional users, such as HR managers, coaches, and therapists, can request a free demo for this or other assessments from ARCH Profile’s extensive battery: http://hrtests.archprofile.com/testdrive_gen_1

To learn more about psychological testing, download this free eBook: http://hrtests.archprofile.com/personality-tests-in-hr

About PsychTests AIM Inc.

PsychTests AIM Inc. originally appeared on the internet scene in 1996. Since its inception, it has become a pre-eminent provider of psychological assessment products and services to human resource personnel, therapists, academics, researchers and a host of other professionals around the world. PsychTests AIM Inc. staff is comprised of a dedicated team of psychologists, test developers, researchers, statisticians, writers, and artificial intelligence experts (see ARCHProfile.com). The company’s research division, Plumeus Inc., is supported in part by Research and Development Tax Credit awarded by Industry Canada.

Share article on social media or email:

Dr. Sergio Yero & Dr. Wilbert D. Yeung of Advanced Psychiatric Associates Named NJ Top Docs

SCOTCH PLAINS, N.J. (PRWEB)
March 04, 2020

NJ Top Docs has reviewed and approved Sergio Yero, MD, FAPA and Wilbert D. Yeung, MD of Advanced Psychiatric Associates for 2019.

Advanced Psychiatric Associates is a behavioral health group practice dedicated to providing the best possible care in a relaxed, comfortable private office setting. They treat children, adolescents, adults, and families with a variety of conditions including anxiety, depression, OCD, addiction, mood disorders, ADHD, and behavioral issues.

These two NJ Top Docs provide a full range of therapies including Cognitive Behavioral Therapy, Couples and Family Therapy, FBT for Eating Disorders, Parent Guidance and Consultation, Psychodynamic Psychotherapy, Psychopharmacology, Suboxone Induction and Maintenance, and Supportive Psychotherapy.

Dr. Sergio Yero is Board Certified in both General Psychiatry and Addiction Psychiatry. His areas of expertise are psychopharmacology, addiction psychiatry, refractory psychiatric illnesses, personality and mood disorders.

You can learn more about Dr. Yero here: https://njtopdocs.com/nj-doctors/dr-sergio-yero/

Dr. Wilbert D. Yeung is an expert in treating depression, mood disorders, anxiety, OCD, ADHD, behavioral issues, and eating disorders in children, adolescents, and adults. He completed a Triple Board Residency in Pediatrics, Psychiatry, Child and Adolescent Psychiatry at Brown University, where he as an Assistant Instructor and Chief Resident.

You can learn more about Dr. Yeung here: https://njtopdocs.com/nj-doctors/wilbertyeungmd/

About Us

NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:

MILWAUKEE (PRWEB)
February 28, 2020

Researchers in behavioral economics use insights from psychology and economics to understand how and why people make certain decisions. Their approaches are starting to influence policies in agriculture.

In the new article published in the Applied Economic Perspectives & Policy, “Agricultural Adoption and Behavioral Economics: Bridging the Gap,” the authors dig into the linkages between research on agricultural technology adoption and behavioral economics. They also highlight three specific opportunities to join these research perspectives to inform evidence-based decision making and policy.

One of the authors, Leah Palm-Forster from the University of Delaware, says, “We felt that there were real opportunities to bring together the two research areas, on behavioral economics and the behavior of farmers, to explore their overlap and to look at key areas where the two bodies of research could enrich each other. We hope this can help make agricultural programs and policies more effective.”

The full team of authors includes AAEA members Nadia Streletskaya (Oregon State University), Samuel Bell (Oregon State University), Maik Kecinski (University of Delaware), Tongzhe Li (University of Windsor), Simanti Banerjee (University of Nebraska-Lincoln), Leah Palm‐Forster (University of Delaware), and David Pannell (University of Western Australia).

The article is available to the public now and you can listen to David Pannell and Leah Palm-Forster’s Podcast here: https://soundcloud.com/user-297451350/aepp-421-2

If you are interested in setting up an interview with Leah or David, please contact Allison Scheetz in the AAEA Business Office.

ABOUT AAEA: Established in 1910, the Agricultural & Applied Economics Association (AAEA) is the leading professional association for agricultural and applied economists, with 2,500 members in more than 60 countries. Members of the AAEA work in academic or government institutions as well as in industry and not-for-profit organizations, and engage in a variety of research, teaching, and outreach activities in the areas of agriculture, the environment, food, health, and international development. The AAEA publishes two journals, the American Journal of Agricultural Economics and Applied Economic Perspectives & Policy, as well as the online magazine Choices and the online open access publication series Applied Economics Teaching Resources. To learn more, visit http://www.aaea.org.

Share article on social media or email:

“Earlier studies of psilocybin and MDD are very encouraging where psilocybin seems to exert effect by a novel fast acting mechanism. I’m very excited to Investigate psilocybin in a clinical trial setting.”Dr. Rishi Kakar

LAUDERHILL, Fla. (PRWEB)
February 27, 2020

Segal Trials, a privately held network of research sites throughout South Florida and South Carolina conducting Phase I-IV trials, is excited to announce the screening of its first patient for a Phase 2 clinical trial (Usona PSIL201) investigating the safety and efficacy of psilocybin for major depressive disorder (MDD).

Dr. Rishi Kakar and his clinical research team, at Segal Trials, at our West Broward Outpatient site will be spearheading this trial for the organization. The Usona study will use a randomized, double-blinded, placebo-controlled design to evaluate the potential antidepressant effects of a single dose of psilocybin in patients with MDD.

The Usona Institute received Breakthrough Therapy Designation from the FDA for the use of psilocybin in the treatment of major depressive disorder. There are over 17 million people in the United States who suffer from major depression, and this breakthrough designation is important as it addresses an unmet need and offers another option that may allow a clinically significant improvement over other therapies on the market.

Data suggest that psilocybin may have behavioral effects relevant to the treatment of depression and recent studies also suggest that psilocybin may possess antidepressant properties. To further assess the effects of psilocybin on MDD signs and symptoms, this trial will assess the safety and efficacy of psilocybin on 80 individuals suffering from MDD at seven sites within the US. Dr. Kakar, of Segal Trials, is proud to be one of these sites, exploring this new breakthrough treatment for depression.

Share article on social media or email:

ASPPB logo

ASPPB will use Certemy to streamline and automate their examination process for psychology boards in all fifty states of the United States, the District of Columbia, the U.S. Virgin Islands, Puerto Rico, Guam, and all ten provinces of Canada.

COSTA MESA, Calif. (PRWEB)
February 20, 2020

Certemy, a leading provider of credentialing management software for certification and licensing organizations, announced today that the Association of State and Provincial Psychology Boards (ASPPB) has selected Certemy to streamline and automate their examination process for all member boards. ASPPB supports state, provincial, and territorial agencies responsible for the licensure of psychologists throughout the United States and Canada. Certemy will replace Pearson Credentialing Manager (PCM), a credentialing software platform that is being phased out by its parent company in 2020.

“Certemy provides all the functionality and customizability we need to replace PCM at a reasonable cost,” said Matthew Turner, Ph.D., Senior Director of Examination Services at the Association of State and Provincial Psychology Boards (ASPPB). “We are confident that Certemy’s product capabilities and industry expertise will ensure a robust and flexible solution for ourselves and our member boards.”

Certemy Benefits for ASPPB

• 
  One comprehensive solution that standardizes, streamlines, and automates the test registration, candidate tracking, and score reporting processes for all ASPPB jurisdictions (member boards) throughout North America and Canada
• Seamless integration with Pearson VUE using Single Sign On (SSO) and automated, API-driven data exchange
• Ability to create and change workflows without custom programming
• Option to customize workflows for individual jurisdictions or regions
• Simplified management of registration invalidations
• Automated collection of online payments with immediate receipt of funds
• Access to aggregated data for reporting, analysis, and decision support
• Option to collect custom data to drive additional insights

Certemy Benefits for ASPPB Jurisdictions (Member Boards)

• Fully automated, ASPPB-approved solution for test registration, candidate tracking, and score reporting
• Automatic system-generated reminders to ensure candidates register and complete tests on time
• Streamlined management of candidate test accommodations

About ASPPB

The Association of State and Provincial Psychology Boards (ASPPB) is the alliance of state, provincial, and territorial agencies responsible for the licensure and certification of psychologists throughout the United States and Canada. ASPPB was formed to serve psychology boards in the two countries. Currently, the psychology boards of all fifty states of the United States, the District of Columbia, the U.S. Virgin Islands, Puerto Rico, Guam and all ten provinces of Canada are members of ASPPB. Learn more about ASPPB at https://www.asppb.net.

About Certemy

Certemy is the most affordable and configurable SaaS software platform for professional credentialing and exam management. Our platform streamlines and automates credentialing and testing workflows to help credentialing organizations become more efficient, transparent, and agile while reducing IT costs and administrative burdens. We help our customers automate exam candidate management and score reporting by integrating with popular test delivery solutions. We deliver the lowest cost of ownership for any comparable solution with predictable SaaS pricing and no implementation or change fees. And we provide the only solution that business users can change themselves without IT help or programming. An active member of the credentialing community, Certemy is a proud member of The Council on Licensure, Enforcement and Regulation (CLEAR), the Institute for Credentialing Excellence (ICE), and the Association of Test Publishers (ATP). Learn more about Certemy at https://certemy.com.

Share article on social media or email:

WCG FDANews

FALLS CHURCH, Va. (PRWEB)
February 19, 2020

How to Deploy Root Cause & CAPA to Minimize Human Error

An FDAnews Webinar

Wednesday, March 4, 2020, 1:00-2:30 p.m. EST

https://www.fdanews.com/minhumanerror

Do employees fail because of process weaknesses that set them up for failure from the start? Does ones procedures provide necessary information and clearly indicate critical steps, along with warnings or cautions associated with the steps? Does ones systems work for manufacturing or the other way around?

Many variables from procedures, training to workplace environment affect human behavior. One needs to understand human behavior and the psychology of error in order to implement a process dedicated to investigating and fixing human errors.

Human Error Solutions’ CEO, an industrial-organizational psychologist and one of the world’s few human error reduction experts, Ginette Collazo, Ph.D., is here to explain how to:

• Determine when human error is a causal factor of quality and compliance issues, as established in GMPs
• Gain better control over human error by incorporating human factors in our process, procedures and systems
• Understand the types of human error, including intentional and unintentional errors of omission and commission
• Measure human error rates by using the root cause determination tool and cognitive load tool
• Track human error and determine trends in quality and compliance by root cause coding structure
• Make predictions regarding human error by diagnostic studies and root cause determination tool coding
• Determine CAPA effectiveness by event reoccurrence and root cause recurrence

While human error may never be eliminated completely, attendees will come away with an understanding of the psychology of error and how to incorporate root cause and CAPA to minimize human error.

Interested in registering multiple sites?

Call 888.838.5578 in the U.S. or +1 703.538.7600 globally to learn about our special multisite discount.

Webinar Details:

How to Deploy Root Cause & CAPA to Minimize Human Error

An FDAnews Webinar

Wednesday, March 4, 2020, 1:00-2:30 p.m. EST

https://www.fdanews.com/minhumanerror

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.fdanews.com/minhumanerror

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

Xtalks Life Science Webinars

The timeline provided by MDR was three years, which extends until 25 May 2020

TORONTO (PRWEB)
February 19, 2020

In 2017, the EU’s revamped Medical Device Regulation (MDR) was published, which expanded the scope of regulations and requirements that currently govern medical device manufacturers under the Medical Devices Directive (MDD); the timeline provided by MDR was three years, which extends until 25 May 2020. Major changes from the previous MDD include:

• 
  Elimination of the “grandfathering” mechanism, which necessitates that all medical devices on the market must apply to be accredited, regardless of whether or not they were previously approved under earlier directives
• Empirical evaluation and testing that demonstrates that devices are biocompatible, in alignment with ISO 10993-1:2018, and not merely relying on historical data that supports a device’s safety
• Documentation that medical devices do not contain carcinogens, mutagens, or reproductive toxic substances. This can be accomplished by identifying and quantifying the materials that compose the medical device above 0.1 percent (by weight)

Join Scott Graham, PhD, Team Leader at EAG and Carolyn J. Otten, PhD, Senior Manager of Analytical Services at EAG in a live webinar on Thursday, March 5, 2020 at 2pm EST (11am PST) to learn about:

• What manufacturers need to know about the EU MDR
• Overview of the scope of testing, the analytical approach and turnaround times involved to address new MDR requirements
• Three examples of the types of tests offered by Eurofins EAG, presented as case studies
• Extractables and leachables studies
• Potential follow-up steps after testing

This webinar will be followed by a live Q&A with the featured speakers.

For more information or to register for this event, visit Are You Prepared for the New Requirements of the EU’s Medical Device Regulation?

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

This intense hatred continued building up in me until sometimes I thought I would choke. – Fiske Hanley II

DALLAS (PRWEB)
February 18, 2020

On the morning of May 31, 1943, less than twenty four hours after his graduation ceremony at Texas Technical College, Fiske Hanley boarded a train and changed his life forever. The train was to take him to Florida to begin his cadet training – he had been drafted by the US army to serve in the Second World War. Nine months later, he was assigned B-29 flight engineer and attached to the 504th Bombardment Group in the Pacific theater, but on his seventh mission, he and the ten other men of his crew were shot down over Japan. He arrived on Japanese soil via parachute and thus began his harrowing experience as a prisoner of war. Accused War Criminal: An American Kempei Tai Survivor (releasing today from Brown Books Publishing Group) is Hanley’s powerful account of his harrowing experiences in World War II, from his training and commissioning, to his deployment and failed mission, to his imprisonment, all the way through his rescue and recovery.

During his imprisonment, Hanley suffered much at the hands of the Kempei Tai and was tortured, starved, and forced to endure extreme conditions in which his wounds were left untended. Though Fiske suffered greatly, he tried to overcome his hatred for his oppressors, even during his imprisonment.

“How many more notches could our hatred go? This intense hatred continued building up in me until sometimes I thought I would choke,” Hanley writes. “All we could do was pray and hope that God heard us, even though I often worried that God would not hear me through such hate. So I tried to overcome it…”

With vibrancy and detailed honesty, this account amazes and humbles the reader as only stories of this level of heroism can. Hanley’s remarkable tale, which began as a way for him to deal with the trauma of being held captive during the war, exemplifies the perseverance of the human spirit in the face of great adversity. Fiske recently celebrated his 100th birthday and is proud to share his story.

For more information about Fiske Hanley and his book, please visit http://www.brownbooks.com/h-l/.

Share article on social media or email: